Nutex Health (NUTX) Receivables (2010 - 2026)

Nutex Health has reported Receivables for 17 years, with the latest figure at $6.3 million in Q1 2026.

• Quarterly Receivables fell 97.85% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 97.85% YoY) and the FY2025 annual result came in at $6.0 million, down 97.42% from the prior year.
• Receivables improved to $6.3 million in Q1 2026 per NUTX's latest filing, from $6.0 million in the prior quarter.
• Over five years, Receivables peaked at $295.1 million in Q1 2025 and troughed at $793946.0 in Q1 2022.
• A 5-year average of $45.6 million and a median of $7.3 million in 2025 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2026: Receivables surged 28525.17% in 2022, then sank 97.85% in 2026.
• Over 5 years, Receivables stood at $58.3 million in 2022, then increased by 0.45% to $58.6 million in 2023, then plunged by 92.66% to $4.3 million in 2024, then jumped by 39.53% to $6.0 million in 2025, then grew by 5.65% to $6.3 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $6.3 million, $6.0 million, and $7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.